RESUMEN
AIM: To investigate the species distribution and antifungal susceptibility profiles of yeast isolates causing invasive infections across Beijing. MATERIALS & METHODS: A total of 1201 yeast isolates recovered from blood and other sterile body fluids were correctly identified by matrix-assisted laser desorption/ionization TOF MS supplemented by DNA sequencing. Antifungal susceptibility testing was performed according to the Clinical and Laboratory Standards Institute broth microdilution method. RESULTS: Candida (95.5%) remained the most common yeast species isolated; Candida albicans (38.8%) and Candida parapsilosis (22.6%) were the leading species of candidemia. Azole resistances were mainly observed in Candida glabrata and Candida tropicalis isolates. CONCLUSION: This study outlined the epidemiologic data of invasive yeast infections and highlighted the need for continuous monitoring of azole resistances among C. glabrata and C. tropicalis isolates in Beijing.
Asunto(s)
Candidiasis Invasiva/epidemiología , Candidiasis Invasiva/microbiología , Pruebas de Sensibilidad Microbiana/métodos , Levaduras/efectos de los fármacos , Levaduras/aislamiento & purificación , Adolescente , Adulto , Anciano , Anfotericina B/farmacología , Antifúngicos , Beijing/epidemiología , Candida/efectos de los fármacos , Candida/genética , Candida/aislamiento & purificación , Candida/patogenicidad , Candida albicans/efectos de los fármacos , Candida albicans/genética , Candida albicans/aislamiento & purificación , Candida albicans/patogenicidad , Candida glabrata/efectos de los fármacos , Candida glabrata/genética , Candida glabrata/aislamiento & purificación , Candida glabrata/patogenicidad , Candida parapsilosis/efectos de los fármacos , Candida parapsilosis/genética , Candida parapsilosis/aislamiento & purificación , Candida parapsilosis/patogenicidad , Candida tropicalis/efectos de los fármacos , Candida tropicalis/genética , Candida tropicalis/aislamiento & purificación , Candida tropicalis/patogenicidad , Candidemia/epidemiología , Candidemia/microbiología , Niño , Preescolar , Farmacorresistencia Fúngica/efectos de los fármacos , Equinocandinas/farmacología , Monitoreo Epidemiológico , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Análisis de Secuencia de ADN , Triazoles/farmacología , Levaduras/genética , Levaduras/patogenicidad , Adulto JovenRESUMEN
Erectile dysfunction (ED) is a common male disease and frequently encountered in Andrology. PDE5 inhibiter can competitively inhibit the hydrolysis of cyclic guanosine monophosphate (cGMP), increase the cGMP concentration in the smooth muscle cells of the corpus cavernosum penis, and achieve the therapeutic effect on ED. Tadalafil can elevate the level of cGMP in the corpus cavernosum and effectively improve ED of various causes and degrees. Tadalafil therapy for ED, characterized by long efficacy, high safety, easy acceptance by patients and their partners, and obvious promotion of patients'self-confidence and natural experience in sexual activities, can achieve satisfactory physiological and psychological results and effectively improve the quality of patients' sexual life. Therefore tadalafil deserves an extensive clinical application in the treatment of ED.
